Melanoma incidence and survival in patients with myelodysplastic syndrome: A matched cohort population-based study - 11/01/21
Doi : 10.1016/j.jaad.2020.04.148
Paola Barriera-Silvestrini, MD a, David D. Xiong, BS a, b, Steven Lewis, MS, MBA c, Thomas Knackstedt, MD a, d, ⁎ 
a Department of Dermatology, MetroHealth System, Cleveland, Ohio
b Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio
c Center for Health Care Research & Policy, MetroHealth System, Cleveland, Ohio
d School of Medicine, Case Western Reserve University, Cleveland, Ohio
∗Reprint requests: Thomas J. Knackstedt, MD, 2500 MetroHealth Dr, Cleveland, OH 441092500 MetroHealth DrClevelandOH44109
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 2
P. 502-505 - février 2021 Retour au numéro
Article précédent
- Feasibility and implementation of portable confocal microscopy for point-of-care diagnosis of cutaneous lesions in a low-resource setting
- Esther E. Freeman, Aggrey Semeere, Miriam Laker-Oketta, Priscilla Namaganda, Hany Osman, Robert Lukande, Devon McMahon, Divya Seth, Linda Oyesiku, Guillermo J. Tearney, Salvador Gonzalez, Milind Rajadhyaksha, R. Rox Anderson, Jeffrey Martin, Dongkyun Kang
- Timing of PCR and antibody testing in patients with COVID-19–associated dermatologic manifestations
- Esther E. Freeman, Devon E. McMahon, George J. Hruza, Jules B. Lipoff, Lars E. French, Lindy P. Fox, Marlys S. Fassett
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?